Role of mTOR in podocyte function and diabetic nephropathy in humans and mice

Markus Gödel, Björn Hartleben, Nadja Herbach, Shuya Liu, Stefan Zschiedrich, Shun Lu, Andrea Debreczeni-Mór, Maja T. Lindenmeyer, Maria Pia Rastaldi, Götz Hartleben, Thorsten Wiech, Alessia Fornoni, Robert G. Nelson, Matthias Kretzler, Rüdiger Wanke, Hermann Pavenstädt, Dontscho Kerjaschki, Clemens D. Cohen, Michael N. Hall, Markus A. RüeggKen Inoki, Gerd Walz, Tobias B. Huber

Research output: Contribution to journalArticle

291 Citations (Scopus)

Abstract

Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.

Original languageEnglish
Pages (from-to)2197-2209
Number of pages13
JournalJournal of Clinical Investigation
Volume121
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Podocytes
Diabetic Nephropathies
Homeostasis
Proteinuria
Human Activities
Hypertrophy
Renal Insufficiency
Disease Progression
Chronic Disease
Morbidity
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., ... Huber, T. B. (2011). Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. Journal of Clinical Investigation, 121(6), 2197-2209. https://doi.org/10.1172/JCI44774

Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. / Gödel, Markus; Hartleben, Björn; Herbach, Nadja; Liu, Shuya; Zschiedrich, Stefan; Lu, Shun; Debreczeni-Mór, Andrea; Lindenmeyer, Maja T.; Rastaldi, Maria Pia; Hartleben, Götz; Wiech, Thorsten; Fornoni, Alessia; Nelson, Robert G.; Kretzler, Matthias; Wanke, Rüdiger; Pavenstädt, Hermann; Kerjaschki, Dontscho; Cohen, Clemens D.; Hall, Michael N.; Rüegg, Markus A.; Inoki, Ken; Walz, Gerd; Huber, Tobias B.

In: Journal of Clinical Investigation, Vol. 121, No. 6, 01.06.2011, p. 2197-2209.

Research output: Contribution to journalArticle

Gödel, M, Hartleben, B, Herbach, N, Liu, S, Zschiedrich, S, Lu, S, Debreczeni-Mór, A, Lindenmeyer, MT, Rastaldi, MP, Hartleben, G, Wiech, T, Fornoni, A, Nelson, RG, Kretzler, M, Wanke, R, Pavenstädt, H, Kerjaschki, D, Cohen, CD, Hall, MN, Rüegg, MA, Inoki, K, Walz, G & Huber, TB 2011, 'Role of mTOR in podocyte function and diabetic nephropathy in humans and mice', Journal of Clinical Investigation, vol. 121, no. 6, pp. 2197-2209. https://doi.org/10.1172/JCI44774
Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. Journal of Clinical Investigation. 2011 Jun 1;121(6):2197-2209. https://doi.org/10.1172/JCI44774
Gödel, Markus ; Hartleben, Björn ; Herbach, Nadja ; Liu, Shuya ; Zschiedrich, Stefan ; Lu, Shun ; Debreczeni-Mór, Andrea ; Lindenmeyer, Maja T. ; Rastaldi, Maria Pia ; Hartleben, Götz ; Wiech, Thorsten ; Fornoni, Alessia ; Nelson, Robert G. ; Kretzler, Matthias ; Wanke, Rüdiger ; Pavenstädt, Hermann ; Kerjaschki, Dontscho ; Cohen, Clemens D. ; Hall, Michael N. ; Rüegg, Markus A. ; Inoki, Ken ; Walz, Gerd ; Huber, Tobias B. / Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 6. pp. 2197-2209.
@article{dad89703c7414236ac535d072c2e78eb,
title = "Role of mTOR in podocyte function and diabetic nephropathy in humans and mice",
abstract = "Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.",
author = "Markus G{\"o}del and Bj{\"o}rn Hartleben and Nadja Herbach and Shuya Liu and Stefan Zschiedrich and Shun Lu and Andrea Debreczeni-M{\'o}r and Lindenmeyer, {Maja T.} and Rastaldi, {Maria Pia} and G{\"o}tz Hartleben and Thorsten Wiech and Alessia Fornoni and Nelson, {Robert G.} and Matthias Kretzler and R{\"u}diger Wanke and Hermann Pavenst{\"a}dt and Dontscho Kerjaschki and Cohen, {Clemens D.} and Hall, {Michael N.} and R{\"u}egg, {Markus A.} and Ken Inoki and Gerd Walz and Huber, {Tobias B.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1172/JCI44774",
language = "English",
volume = "121",
pages = "2197--2209",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Role of mTOR in podocyte function and diabetic nephropathy in humans and mice

AU - Gödel, Markus

AU - Hartleben, Björn

AU - Herbach, Nadja

AU - Liu, Shuya

AU - Zschiedrich, Stefan

AU - Lu, Shun

AU - Debreczeni-Mór, Andrea

AU - Lindenmeyer, Maja T.

AU - Rastaldi, Maria Pia

AU - Hartleben, Götz

AU - Wiech, Thorsten

AU - Fornoni, Alessia

AU - Nelson, Robert G.

AU - Kretzler, Matthias

AU - Wanke, Rüdiger

AU - Pavenstädt, Hermann

AU - Kerjaschki, Dontscho

AU - Cohen, Clemens D.

AU - Hall, Michael N.

AU - Rüegg, Markus A.

AU - Inoki, Ken

AU - Walz, Gerd

AU - Huber, Tobias B.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.

AB - Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=79957881425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957881425&partnerID=8YFLogxK

U2 - 10.1172/JCI44774

DO - 10.1172/JCI44774

M3 - Article

C2 - 21606591

AN - SCOPUS:79957881425

VL - 121

SP - 2197

EP - 2209

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -